Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid

Apoptosis

Volumn 8, Issue 2, 2003, Pages 161-169

  Smith, H J ^a   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cancer cachexia; Eicosapentaenoic acid; Proteolysis; Proteolysis inducing factor

Indexed keywords

ARACHIDONIC ACID; CASPASE 2; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 6; CASPASE 8; CASPASE 9; CHYMOTRYPSIN; CYTOCHROME C; DNA FRAGMENT; GLYCOPROTEIN; ICOSAPENTAENOIC ACID; PROTEASOME; PROTEIN BAX; PROTEIN BCL 2; PROTEOLYSIS INDUCING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CACHEXIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DNA STRAND BREAKAGE; ENZYME ACTIVITY; MOUSE; MYOTUBE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PROTEINS; BLOTTING, WESTERN; CACHEXIA; CELL LINE; CELLS, CULTURED; CHYMOTRYPSIN; CYSTEINE ENDOPEPTIDASES; CYTOCHROMES C; CYTOSOL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; NUCLEOSOMES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

ANIMALIA; MURINAE;

EID: 0038713079     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022970609579     Document Type: Article

References (24)

1. Fearon KCH. The mechanisms and treatment of weight loss in cancer. Proc Nutri Soc 1992; 51: 251-265.
2. Bistrian BR, Blackburn GL, Scrimshaw NS, Flatt, JP. Cellular immunity in semistarved states in hospitalized adults. Am J Clin Nutr 1978; 28: 1148-1153.
3. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 35: 503-509.
4. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996; 379: 739-742.
5. 12 myoblasts: Modulation by eicosapentaenoic acid. Cancer Res 1999; 59: 5507-5513.
6. Lorite MJ, Cariuk P, Tisdale MJ. Induction of muscle protein degradation by a tumour factor. Br J Cancer 1997; 76: 1035-1040.
7. Williams A, Sun X, Fischer JE, Hasselgren P-O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999; 126: 744-750.
8. Lorite MJ, Smith HJ, Arnold JA, Morris JA, Thompson MG, Tisdale MJ. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001; 85: 297-302.
9. Allen DL, Linderman JK, Roy RR, et al. Apoptosis: A mechanism contributing to the remodelling of skeletal muscle in response to hindlimb unweighting. Am J Physiol 1997; 273: C579-C587.
10. Tews DS, Goebel HH, Meinck HM. DNA fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand 1997; 96: 380-386.
11. van Royen M, Carbo N, Busquets S, et al. DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? Biochem Biophys Res Commun 2000; 270: 533-537.
12. Yoshida H, Ishiko O, Sumi T, Honda K, Hirai K, Ogita S. Expression of apoptosis regulatory proteins in the skeletal muscle of tumor-bearing rabbits. Jpn J Cancer Res 2001; 92: 631-637.
13. Belizario JE, Lorite MJ, Tisdale MJ. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscle from mice undergoing cancer cachexia. Br J Cancer 2001; 84: 1135-1140.
14. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway. J Exp Med 1999; 189: 1815-1822.
15. Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 1996; 56: 1256-1261.
16. Orino E, Tanaka K, Tamura T, Sone S, Ogura T, Ichihara A. ATP-dependent reversible association of proteasomes with multiple protein compartments to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett 1991; 284: 206-210.
17. Kisselev AF, Akopian TN, Castillo V, Goldberg AL. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Molecular Cell 1999; 4: 395-402.
18. Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 2001; 61: 3604-3609.
19. Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999; 274: 17484-17490.
20. 2+-dependent systems. Adv Mol Cell Biol 1998; 27: 235-266.
21. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 80-86.
22. Kidd VJ, Lahti JM, Teitz T. Proteolytic regulation of apoptosis. Cell Dev Biol 2000; 11: 191-201.
23. Cao Y, Pearman A, Zimmerman GA, McIncyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000; 97: 11280-11285.
24. Narula J, Pandey P, Arbustini EB, et al. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 1999; 96: 8144-8149.